Abstract
Prostate-specific antigen (PSA) is a serine protease with chymotripsine-like enzymatic activity, produced primarily by the prostate gland. It is widely used as a marker of androgen sensitive-prostate cancer. Likewise, women with androgen-dependent hirsutism have increased serum PSA levels. The aim of the present study was to investigate whether female patients with Cushing’s disease had increased serum PSA concentrations. We studied 22 patients with active Cushing’s disease. Twelve out of 22 patients were also evaluated after remission of the disease. Forty normal women with no signs of hirsutism served as controls. Mean serum PSA levels were higher in patients with active Cushing’s disease than controls (p=0.005). Mean serum PSA levels decreased after remission of the disease (33.7±63.3 pg/ml vs 2.2±3.0 pg/ml, p<0.002, in active and cured patients, respectively). All patients with high serum PSA levels had a normalization of this parameter after the disease was cured. Serum T, DHEAS and ‡4 concentrations decreased after the remission of Cushing’s disease. A positive correlation was found between serum PSA and T values (r=0.6, p<0.05). In conclusion, elevated serum PSA values are markers of androgen activity in female with Cushing’s disease and their normalization may represent an additional index of remission of the disease.
This is a preview of subscription content, log in via an institution to check access.
References
McCormack R.T., Rittenhouse H.G., Finlay J.A., et al. Molecular forms of prostate specific antigen and the human kallicrein gene family: a new era. Urology. 1995, 45: 729–744.
Catalona W.J, Smith D.S., Ratliff T.L., et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N. Engl. J. Med. 1991, 324: 1156–1161.
Melegos D.N., Yu H., Ashok M., Wang C., Stanczyk F., Diamandis E.P. Prostate-specific antigen in female serum, a potential new marker of androgen excess. J. Clin. Endocrinol. Metab. 1997, 82: 777–780.
Escobar-Morreale H.F., Serrano-Gotarredona J., Avila S., Villar-Palasì J., Varela C., Sancho J. The increased circulating prostate-specific antigen concentrations in women with hirsutism do not respond to acute changes in adrenal or ovarian function. J. Clin. Endocrinol. Metab. 1998, 83: 2580–2584.
Negri C., Tosi F., Dorizzi R., et al. Antiandrogen drugs lower serum prostate-specific antigen (PSA) levels in hirsute subjects: evidence that serum PSA is a marker of androgen action in women. J. Clin. Endocrinol. Metab. 2000, 85: 81–84.
Obiezu C.V., Scorilas A., Magklara A., et al. Prostate-specific antigen and human glandular kallikrein 2 are markedly elevated in urine of patients with polycistic ovary syndrome. J. Clin. Endocrinol. Metab. 2001, 86: 1558–1561.
Diamandis E.P., Yu H. New biological functions of prostate specific antigen? J. Clin Endocrinol. Metab. 1995, 80: 1515–1517.
Luke M.C., Coffey D.S. Human androgen receptors binding to the androgen response element of prostate specific antigen. J. Androl. 1994, 15: 41–51.
Magklara A., Grass L., Diamandis E.P. Differential steroid hor- mone regulation of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) in breast cancer cell lines. Breast Cancer Res. Treat. 2000, 59: 263–270.
Pimentel-Filho F.R., Cukiert A., Miyashita F., et al. Adrenocorticotropin levels do not change during early recovery of transsphenoidal surgery for ACTH-secreting pituitary tumors. J. Endocrinol. Invest. 2001, 24: 83–87.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Manetti, L., Lupi, I., Bogazzi, F. et al. Prostate-specific antigen is increased in female patients with Cushing’s disease. J Endocrinol Invest 25, RC29–RC31 (2002). https://doi.org/10.1007/BF03345504
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03345504